UnitedHealth Group Gains $1.17M Lee Financial Stake as Jefferies Cuts Target to $340

UNHUNH

Lee Financial Co bought 3,390 UNH shares valued at $1.17M in Q3, joining Brighton Jones’ 176.2% increase to 44,249 shares and pushing institutional ownership to 87.86%. Jefferies cut its UNH price target from $418 to $340, pulling the consensus target down to $376.75 and signaling caution.

1. Premium Valuation Under Reevaluation

UnitedHealth Group has historically traded at a significant premium to peers due to its diversified revenue streams and strong cash flow generation. Over the past year, however, the shares have underperformed major benchmarks by more than 15%, prompting investors to question whether the company’s current valuation still reflects its industry leadership. With a forward price-earnings multiple exceeding 20 and a PEG ratio above 1.3, market participants are weighing slowing membership growth in commercial plans against continued expansion in its Optum services unit.

2. Institutional Investors Adjust Stakes

Recent SEC filings reveal that Lee Financial Co initiated a stake of 3,390 shares during the third quarter, investing around $1.17 million into the health care giant. Brighton Jones LLC and Revolve Wealth Partners LLC also boosted their holdings by 176% and 137% respectively in the fourth quarter, adding a combined 30,000 shares valued at over $24 million. At the same time, UMB Bank N.A. trimmed its position by more than 25%, selling roughly 11,000 shares. Overall, institutional ownership remains high at nearly 88%, underscoring the stock’s importance in large-cap portfolios.

3. Analyst Ratings and Earnings Outlook

Wall Street consensus remains cautiously optimistic, with 17 analysts maintaining a Buy rating and an average target multiple implying mid-teens upside. Jefferies cut its target multiple by over 20% but retained a Buy rating, while Oppenheimer lowered its objective yet kept an Outperform stance. In the latest quarter, UnitedHealth reported revenue growth of 12.3% year-over-year to $113.2 billion and delivered adjusted EPS 2 cents above consensus at $2.11. The company reiterated full-year EPS guidance of approximately $17.75 and projected continued margin expansion driven by Optum technology services.

4. Dividend Yield Supports Total Return

UnitedHealth’s quarterly dividend of $2.21 per share results in an annualized payout of $8.84 and a yield near 3.1%. With a payout ratio of 67%, management has emphasized a balanced approach to returning capital via dividends and share repurchases. Over the past five years, total cash returned has exceeded $50 billion, reflecting confidence in the underlying business model and its ability to generate free cash flow in both stable and inflationary environments.

Sources

FDDDD